The Greens' agreement on the Merz plan gives a boost to the German stock exchange, dragging it up on all European markets.
Novo Nordisk (NVO), the company behind popular diabetes and obesity treatments Ozempic and Wegovy, saw its stock rise on Thursday after ...
Novo Nordisk (NVO) ended a five-day losing streak on Thursday after Kepler Cheuvreux, a long-time skeptic of the Danish biotech, finally issued a bullish rating on the maker of hugely popular obesity/ ...
European markets are expected to open in mixed territory Thursday, stumbling lower as President Donald Trump’s tariffs policy upends global trading relations.
Kepler Cheuvreux re-initiated coverage of Mowi (MHGVY) with a Buy rating and NOK 266 price target The firm believes the company’s harvest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results